Ivabradine
Brands: Corlanor · Ivabradine Hydrochloride
9 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 8 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 4 | SUPPLYING |
| Bionpharma Inc. | unknown | 4 | SUPPLYING |
| Amgen, Inc | unknown | 3 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 2 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 4, 2026RECALLRecall (Class II): Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC…
Presence of Foreign Substance. — Recalling firm: Amgen, Inc. — Nationwide within the United States
- Jun 4, 2026RECALLRecall (Class II): Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (ND…
Presence of Foreign Substance. — Recalling firm: Amgen, Inc. — Nationwide within the United States
- Mar 24, 2026RESOLVEDShortage resolved: Ivabradine Hydrochloride Tablet (Amgen Inc.)
Ivabradine Hydrochloride Tablet — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
- Mar 24, 2026SHORTAGEDrug shortage: Ivabradine Hydrochloride Tablet (Amgen Inc.)
Ivabradine Hydrochloride Tablet — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
- Mar 24, 2026RESOLVEDShortage resolved: Ivabradine Solution (Amgen Inc.)
Ivabradine Solution — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
- Mar 24, 2026SHORTAGEDrug shortage: Ivabradine Solution (Amgen Inc.)
Ivabradine Solution — reported in shortage by Amgen Inc.. Therapeutic category: Cardiovascular.
Pill